ClinicalTrialsFinder

Double-Expressor Lymphoma Clinical Trials in Pittsburgh, Pennsylvania

1 recruitingPittsburgh, Pennsylvania

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Testing the Safety of Anti-Cancer Drug, CX-5461 (Pidnarulex), in Treating Lymphoma With Specific Changes in the MYC Gene

Burkitt LymphomaHigh Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 RearrangementsDouble-Expressor Lymphoma
National Cancer Institute (NCI)50 enrolled4 locationsNCT07069699